CHICAGO, IL, Vermillio, the AI licensing and protection platform, announces that it has raised $16 million in Series A funding, led by Sony Music Entertainment and DNS Capital.
Read More

NEW YORK, NY, HeyMilo, an AI-powered candidate screening platform, announced $2.2 million in seed funding. The round, led by Canaan Partners, underscores the growing demand for innovative technologies.
Read More

JUPITER, FL, Myosin Therapeutics, Inc., a biotechnology company developing novel therapies for cancer and neurological disorders, has closed its second seed funding round, raising over $3 million.
Read More

CAMPBELL, CA, Atmosic Technologies, a leader in ultra-low power compute and connectivity solutions, announced it has successfully raised $40M in Series-D funding.
Read More

BOSTON, MA, Newleos Therapeutics, a clinical stage neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug development, announced the closing of an oversubscribed $93.5 million Series A financing.
Read More

NEW YORK, NY, Viam, the engineering platform for data, AI and automation, announced $30 million in Series C funding, led by existing investor Union Square Ventures with participation from Battery Ventures, Neurone, and other existing investors.
Read More

PHILADELPHIA, PA, Founded and led by junior high innovator Max Kopp from Germantown Academy, Vitasense has secured significant funding from Crown Wealth.
Read More